Dr. Lori Leslie, MD
Claim this profileHackensack Meridian Health (Data collection only)
Area of expertise
Lymphoma
Lori Leslie, MD has run 4 trials for Lymphoma. Some of their research focus areas include:
Non-Hodgkin's Lymphoma
Lori Leslie, MD has run 4 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Hackensack Meridian Health (Data Collection Only)
Hackensack Meridian Health - John Theurer Cancer Center
Clinical Trials Lori Leslie, MD is currently running
Mosunetuzumab
for Follicular Lymphoma
This trial is testing mosunetuzumab, a drug that helps the immune system fight cancer, in people newly diagnosed with follicular lymphoma.
Recruiting
1 award
Phase 2
Cema-cel
for B-Cell Lymphoma
This is a randomized, open-label study in adult patients who have completed standard first line therapy for large B-cell lymphoma (LBCL) and achieved a complete response or partial response suitable for observation, but who have minimal residual disease (MRD) as detected by the Foresight CLARITY™ Investigational Use Only (IUO) MRD test, powered by PhasED-Seq™. The purpose of the trial is to assess the efficacy and safety of consolidation with cemacabtagene ansegedleucel (cema-cel), an allogeneic CD19 CAR T product, as compared to standard of care observation. In this study, participants with MRD are randomized 1:1 to treatment with cema-cel or an observation arm. Treatment includes cema-cel following a lymphodepletion regimen of fludarabine and cyclophosphamide. Prior to August 2025, participants may also have received an anti-CD52 monoclonal antibody, ALLO-647, as part of their lymphodepletion regimen.
Recruiting
1 award
Phase 2
5 criteria
More about Lori Leslie, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Lori Leslie, MD has experience with
- Ibrutinib
- Rituximab
- Obinutuzumab
- Cirmtuzumab
- Lenalidomide
- Tazemetostat
Breakdown of trials Lori Leslie, MD has run
Lymphoma
Non-Hodgkin's Lymphoma
Acute Lymphocytic Leukemia
MALT Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lori Leslie, MD specialize in?
Lori Leslie, MD focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved Stage III patients, or patients who are Stage IV.
Is Lori Leslie, MD currently recruiting for clinical trials?
Yes, Lori Leslie, MD is currently recruiting for 2 clinical trials in Hackensack New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Lori Leslie, MD has studied deeply?
Yes, Lori Leslie, MD has studied treatments such as Ibrutinib, Rituximab, Obinutuzumab.
What is the best way to schedule an appointment with Lori Leslie, MD?
Apply for one of the trials that Lori Leslie, MD is conducting.
What is the office address of Lori Leslie, MD?
The office of Lori Leslie, MD is located at: Hackensack Meridian Health (Data collection only), Hackensack, New Jersey 07601 United States. This is the address for their practice at the Hackensack Meridian Health (Data collection only).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.